A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11).

Hyun Ae Jung Keon Uk Park Sang Hee Cho Jinyeong Lim Keun-Wook Lee Min Hee HongTak YunHo Jung An Woong-Yang Park Sergio Pereira Chan-Young Ock Bhumsuk Keam

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Nivolumab plus gemcitabine showed promising efficacy with favorable toxicity profiles in patients with advanced NPC in whom platinum-based combination chemotherapy failed.

Keyphrases

locally advanced
phase ii study
squamous cell carcinoma
rectal cancer
radiation therapy
small cell lung cancer
oxidative stress
open label
clinical trial
randomized controlled trial
study protocol